突变分析揭示妊娠相关骨质疏松女性中的单基因骨病:LRP5、COL1A1和COL1A2的三个新突变
这项前瞻性研究对7例连续妊娠相关骨质疏松(PAO)病例进行骨骼评估和定制基因面板分析,发现所有病例骨密度降低且脊柱受累更重,基因分析检出LRP5、COL1A1和COL1A2三个新突变,提示妊娠可促进先前未识别的单基因骨病临床发病,钙稳态正常化是治疗重点。
要点
- 7例PAO病例均显示骨密度降低,腰椎T值-3.2±1.0,左股骨-2.2±0.5,右股骨-1.9±0.5。
- 基因分析检出LRP5、COL1A1和COL1A2三个新突变,提示单基因骨病在PAO中起重要作用。
- 妊娠应被视为骨骼风险因素,可促进遗传决定的低骨量个体中单基因骨病的初始临床发病。
核心结论
- 研究数据表明,先前未识别的单基因骨病在妊娠相关骨质疏松(PAO)中起重要作用。
- 妊娠应被视为一种骨骼风险因素,可促进此类骨骼疾病的初始临床发病。
- 潜在的钙需求增加对预防和治疗措施至关重要,尤其对遗传决定的低骨量个体。
- 将这一知识应用于临床实践可促使骨骼部分恢复。
- 需要一致的遗传学研究来分析PAO女性中致病性变异的频率。
研究设计与样本
- 前瞻性研究纳入7例连续诊断PAO的病例。
- 所有病例接受骨骼评估(血液检查、DXA、HR-pQCT)和定制基因面板的全面遗传分析。
主要发现
- 所有病例均显示骨密度降低:DXA T值腰椎-3.2±1.0,左股骨-2.2±0.5,右股骨-1.9±0.5。
- 脊柱受累较股骨更严重(p<0.05)。
- HR-pQCT显示小梁和皮质厚度总体降低,大多数病例小梁数量未见改变。
- 基因分析揭示LRP5、COL1A1和COL1A2三个新突变。
关键数值与推荐
- PAO诊断基于妊娠和哺乳过程中骨密度降低,典型症状包括椎体压缩骨折和髋部暂时性骨质疏松。
- DXA T值腰椎-3.2±1.0,左股骨-2.2±0.5,右股骨-1.9±0.5,脊柱较股骨受累更严重(p<0.05)。
临床怎么用
- 治疗措施应尤其关注钙稳态紊乱的正常化,以实现骨骼的部分恢复。
- 预防和治疗措施应特别针对遗传决定的低骨量个体。
- 将遗传学知识应用于临床实践可使骨骼部分恢复。
局限性
- 需要一致的遗传学研究来分析PAO女性中致病性变异的频率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Pregnancy was found to be a skeletal risk factor promoting the initial onset of previously unrecognized monogenic bone disorders, thus explaining a proportion of cases with pregnancy-associated osteoporosis. Therapeutic measures should focus in particular on the normalization of the disturbed calcium homeostasis in order to enable the partial skeletal recovery. INTRODUCTION: Pregnancy-associated osteoporosis (PAO) is a rare skeletal condition, which is characterized by a reduction in bone mineral density (BMD) in the course of pregnancy and lactation. Typical symptoms include vertebral compression fractures and transient osteoporosis of the hip. Since the etiology is not well understood, this prospective study was conducted in order to elucidate the relevance of pathogenic gene variants for the development of PAO. METHODS: Seven consecutive cases with the diagnosis of PAO underwent a skeletal assessment (blood tests, DXA, HR-pQCT) and a comprehensive genetic analysis using a custom-designed gene panel. RESULTS: All cases showed a reduced BMD (DXA T-score, lumbar spine - 3.2 ± 1.0; left femur - 2.2 ± 0.5; right femur - 1.9 ± 0.5), while the spine was affected more severely (p < 0.05). The trabecular and cortical thickness was overall reduced in HR-pQCT, while the trabecular number showed no alterations in most cases. The genetic analysis revealed three novel mutations in LRP5, COL1A1, and COL1A2. CONCLUSION: Our data show that previously unrecognized monogenic bone disorders play an important role in PAO. Pregnancy should be considered a skeletal risk factor, which can promote the initial clinical onset of such skeletal disorders. The underlying increased calcium demand is essential in terms of prophylactic and therapeutic measures, which are especially required in individuals with a genetically determined low bone mass. The implementation of this knowledge in clinical practice can enable the partial recovery of the skeleton. Consistent genetic studies are needed to analyze the frequency of pathogenic variants in women with PAO.
引用
- Butscheidt S, Delsmann A, Rolvien T, et al. Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2. Osteoporos Int. 2018. PMID: 29594386. doi:10.1007/s00198-018-4499-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。